Viking Therapeutics has completed enrollment in its Phase 3 VANQUISH-2 trial for VK2735, a significant step towards addressing obesity and type 2 diabetes. As the company prepares to release critical trial data in the coming months, speculation surrounding a potential buyout ramps up, with analysts noting the stock could surge if outcomes are positive. Despite ongoing concerns about projected losses and cash burn, VKTX is viewed as an undervalued player in the obesity treatment market, with its current share price far below analyst targets.
“$VKTX will shine too, just a matter of time”
“$MDGL any news? No complaints though. A buyout would be a huge news for shareholders. $VKTX”
“Thanks to the Wegovi pill the doctors shifted from valuing 'how much weight is lost' to 'how long the patient stays on the drug.' $VKTX flexibility is the biggest help to increase adherence.”
“$VKTX is asking for more. Viking is seeing the blinded data and sharing it with other pharma CEOs.”
“$VKTX should be a good year for Viking therapeutics as we head into the 2nd half of 2026 with Maintenance data and Ph1 SAD data from Amylin is expected by year-end.”
“$VKTX Completes Enrollment in Phase 3 VANQUISH-2 Trial of VK2735. 78-Wk Study Evaluating Subcutaneous VK2735 in Adults with Obesity and Type 2 Diabetes.”
“$VKTX - Viking Therapeutics Announces Completion of Enrollment in Phase 3 VANQUISH-2 Trial of VK2735.”
“There's a biological basis for why $VKTX might provide better maintenance: the longer half-life and later Tmax.”
“Viking maintenance study will prove: 1. the minimum effective dose to maintain weight without the side effects of high-dose induction.”
“Viking maintenance study will prove: 2. the convenience of having same-molecule injectable and oral.”
“Actually, I disagree. The $VKTX maintenance data is more important than the weight loss data for two reasons: Stopping the drug cause a metabolic whiplash so good maintenance drugs will be the priority for doctors and the FDA.”
“The more important question for the FDA and patients is: 'How can we keep the weight off forever?'”